Specific down-regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicin

Molecular Cancer

Volumn 5, Issue , 2006, Pages

  Spee, Bart ^a   Jonkers, Martijn D B ^a   Arends, Brigitte ^a   Rutteman, Gerard R ^a   Rothuizen, Jan ^a   Penning, Louis C ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLBUSULFAN; DOXORUBICIN; MESSENGER RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT; BIOASSAY; BREAST CARCINOMA; CARCINOMA CELL; CONTROLLED STUDY; DOG; DOWN REGULATION; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG SENSITIVITY; FREQUENCY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; DOGS; DOWN-REGULATION; DOXORUBICIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEOSTASIS; INHIBITOR OF APOPTOSIS PROTEINS; MEMBRANE GLYCOPROTEINS; RNA INTERFERENCE; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 33748877766     PISSN: 14764598     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-5-34     Document Type: Article

References (36)

1. Nachmias B, Ashhab Y, Ben-Yehuda D: The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol 2004, 14:231-243.
2. Deveraux QL, Takahashi R, Salvesen GS, Reed JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997, 388:300-304.
3. Stennicke HR, Ryan CA, Salvesen GS: Reprieval from execution: the molecular basis of caspase inhibition. Trends Biochem Sci 2002, 27:94-101.
4. Kim R: Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 2005, 103:1551-1560.
5. Bergman PJ: Mechanisms of anticancer drug resistance. Vet Clin North Am Small Anim Pract 2003, 33:651-667.
6. Boatright KM, Salvesen GS: Mechanisms of caspase activation. Curr Opin Cell Biol 2003, 15:725-731.
7. Hofmann HS, Simm A, Hammer A, Silber RE, Bartling B: Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. J Cancer Res Clin Oncol 2002, 128:554-560.
8. Krajewska M, Krajewski S, Banares S, Huang X, Turner B, Bubendorf L, Kallioniemi OP, Shabaik A, Vitiello A, Peehl D, Gao GJ, Reed JC: Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res 2003, 9:4914-4925.
9. Shiraki K, Sugimoto K, Yamanaka Y, Yamaguchi Y, Saitou Y, Ito K, Yamamoto N, Yamanaka T, Fujikawa K, Murata K, Nakano T: Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma. Int J Mol Med 2003, 12:705-708.
10. Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB: Characterization of XIAP-deficient mice. Mol Cell Biol 2001, 21:3604-3608.
11. Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, Durkin JP, Mayer LD, Lacasse EC: Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res 2003, 9:2826-2836.
12. McManus DC, Lefebvre CA, Cherton-Horvat G, St-Jean M, Kandimalla ER, Agrawal S, Morris SJ, Durkin JP, Lacasse EC: Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics. Oncogene 2004, 23:8105-8117.
13. Huang Y, Lu M, Wu H: Antagonizing XIAP-mediated caspase-3 inhibition. Achilles' heel of cancers? Cancer Cell 2004, 5:1-2.
14. Vail DM, MacEwen EG: Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 2000, 18:781-792.
15. van Leeuwen I, Hellmen E, Cornelisse CJ, Van den BB, Rutteman GR: P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog. Anticancer Res 1996, 16:3737-3744.
16. Amantana A, London CA, Iversen PL, Devi GR: X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther 2004, 3:699-707.
17. Schimmer AD, Welsh K, Pinilla C, Wang Z, Krajewska M, Bonneau MJ, Pedersen IM, Kitada S, Scott FL, Bailly-Maitre B, Glinsky G, Scudiero D, Sausville E, Salvesen G, Nefzi A, Ostresh JM, Houghten RA, Reed JC: Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell 2004, 5:25-35.
18. Wang S, El-Deiry WS: TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 2003, 22:8628-8633.
19. Cagliero E, Ferracini R, Morello E, Scotlandi K, Manara MC, Buracco P, Comandone A, Baroetto PR, Baldini N: Reversal of multidrug-resistance using Valspodar (PSC 833) and doxorubicin in osteosarcoma. Oncol Rep 2004, 12:1023-1031.
20. Macy DW, Ensley BA, Gillette EL: In vitro susceptibility of canine tumor stem cells to doxorubicin. Am J Vet Res 1988, 49:1903-1905.
21. Scherr M, Morgan MA, Eder M: Gene silencing mediated by small interfering RNAs in mammalian cells. Curr Med Chem 2003, 10:245-256.
22. Sorensen DR, Leirdal M, Sioud M: Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 2003, 327:761-766.
23. Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T: A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res 2004, 64:3365-3370.
24. Zender L, Hutker S, Liedtke C, Tillmann HL, Zender S, Mundt B, Waltemathe M, Gosling T, Flemming P, Malek NP, Trautwein C, Manns MP, Kuhnel F, Kubicka S: Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci U S A 2003, 100:7797-7802.
25. Dykxhoorn DM, Novina CD, Sharp PA: Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 2003, 4:457-467.
26. Gilmore IR, Fox SP, Hollins AJ, Sohail M, Akhtar S: The design and exogenous delivery of siRNA for post-transcriptional gene silencing. J Drug Target 2004, 12:315-340.
27. Ma Y, Manolache S, Denes FS, Thamm DH, Kurzman ID, Vail DM: Plasma synthesis of carbon magnetic nanoparticles and immobilization of doxorubicin for targeted drug delivery. J Biomater Sci Polym Ed 2004, 15:1033-1049.
28. Li Y, Jian Z, Xia K, Li X, Lv X, Pei H, Chen Z, Li J: XIAP is related to the chemoresistance and inhibited its expression by RNA interference sensitize pancreatic carcinoma cells to chemotherapeutics. Pancreas 2006, 32:288-296.
29. Yamaguchi Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Saitou Y, Sugimoto K, Nakano T: Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death. Oncol Rep 2005, 14:1311-1316.
30. Zhang Y, Wang Y, Gao W, Zhang R, Han X, Jia M, Guan W: Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo. Breast Cancer Res Treat 2006, 96:267-277.
31. Cummings J, Ward TH, LaCasse E, Lefebvre C, St-Jean M, Durkin J, Ranson M, Dive C: Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer 2005, 92:532-538.
32. Schimmer AD, Dalili S, Batey RA, Riedl SJ: Targeting XIAP for the treatment of malignancy. Cell Death Differ 2006, 13:179-188.
33. Boomkens SY, Spee B, Ijzer J, Kisjes R, Egberink HF, van I, Rothuizen J, Penning LC: The establishment and characterization of the first canine hepatocellular carcinoma cell line, which resembles human oncogenic expression patterns. Comp Hepatol 2004, 3:9.
34. Oda D, Savard CE, Nguyen TD, Eng L, Swenson ER, Lee SP: Dog pancreatic duct epithelial cells: long-term culture and characterization. Am J Pathol 1996, 148:977-985.
35. Spee B, Mandigers PJ, Arends B, Bode P, van I, Hoffmann G, Rothuizen J, Penning LC: Differential expression of copper-associated and oxidative stress related proteins in a new variant of copper toxicosis in Doberman pinschers. Comp Hepatol 2005, 4:3.
36. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3:RESEARCH0034.